Brief: Trevi Therapeutics Announces Appointment Of David Hastings As Chief Financial Officer
04/12/2025 12:54
Dec 4 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID HASTINGS AS CHIEF FINANCIAL OFFICER TREVI THERAPEUTICS INC - DAVID HASTINGS TO ASSUME CFO ROLE ON JANUARY 6, 2026 Source text: ID:nPn5YKSVGa Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million